ZLAB Zai Lab Limited - American Depositary Shares
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$24,33
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$15,96mínimo 52 semanas
$34,07máximo 52 semanas
Capitalización Bursátil (MRQ)
$27.31B
P/E (TTM)
-135.2
BPA (TTM)
$-0.18
Ingresos (TTM)
$450M
tus insignias
Rango 52S
$16–$34
Calificación del Analista
BUY
Precio Objetivo
$33
P/E
-135.2
ROE
-26.9%
Margen de Beneficio Neto
-41.9%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
ZLAB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$24.33
Capitalización Bursátil (MRQ)
$27.31B
P/E (TTM)
-135.2
BPA (TTM)
$-0.18
Ingresos (TTM)
$450M
ROE (TTM)
-26.9%
Deuda/Capital (MRQ)
0.4
Rango 52S
$16–$34
ZLAB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Acerca de Zai Lab Limited - American Depositary Shares Descripción general de la empresa de Wikipedia
sectorHealthcare
industriaBiotechnology
empleados1 784
paísCN
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$460M2018-12-31 → 2025-12-31
BPA$-0.162020-12-31 → 2025-12-31
Flujo de caja libre$-159M2020-12-31 → 2025-12-31
Margen neto-41.9%2020-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | ZLAB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -135.2promedio 5A ≈-87.7 | ≈-87.7 | · | · | |
| P/S (TTM) | 60.7promedio 5A ≈63.6 | ≈63.6 | · | · | |
| P/C (MRQ) | 45.0promedio 5A ≈24.6 | ≈24.6 | · | · | |
| EV / EBITDA (TTM) | -108.5 | · | · | · | |
| Precio / FCF (TTM) | -195.7promedio 5A ≈-97.7 | ≈-97.7 | · | · | |
| Precio / Flujo de Caja (TTM) | -204.7promedio 5A ≈-101.5 | ≈-101.5 | · | · | |
| EV / Ingresos (TTM) | 59.9 | · | · | · | |
| EV / FCF (TTM) | -192.9 | · | · | · | |
| Precio / Valor Contable Tangible (MRQ) | 52.4promedio 5A ≈26.6 | ≈26.6 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | ZLAB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -58.7%promedio 5A ≈-185.8% | ≈-185.8% | · | · | |
| Margen EBITDA (TTM) | -55.2%promedio 5A ≈-182.2% | ≈-182.2% | · | · | |
| Margen antes de impuestos (TTM) | -42.4%promedio 5A ≈-179.0% | ≈-179.0% | · | · | |
| Margen de Beneficio Neto (TTM) | -41.9%promedio 5A ≈-179.1% | ≈-179.1% | · | · | |
| ROA (TTM) | -16.8%promedio 5A ≈-29.0% | ≈-29.0% | · | · | |
| ROE (TTM) | -26.9%promedio 5A ≈-36.2% | ≈-36.2% | · | · | |
| ROIC | -24.5%promedio 5A ≈-33.2% | ≈-33.2% | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | ZLAB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.4 | · | · | · | |
| Ratio corriente (MRQ) | 2.1promedio 5A ≈4.6 | ≈4.6 | · | · | |
| Ratio Rápido (MRQ) | 1.6promedio 5A ≈4.2 | ≈4.2 | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | ZLAB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 15.3%promedio 5A ≈66.5% | ≈66.5% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 28.9%promedio 5A ≈48.4% | ≈48.4% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 56.5% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | ZLAB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.4promedio 5A ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover (Rotación de Inventario) | 3.3promedio 5A ≈3.1 | ≈3.1 | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 4.8promedio 5A ≈5.3 | ≈5.3 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$257.9K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
17.0%
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | $-0.05 | $-0.07 | 24.0% | |
| 31 de marzo de 2026 | $-0.05 | $-0.05 | -4.4% | |
| 31 de diciembre de 2025 | $-0.05 | $-0.07 | 24.0% | |
| 30 de septiembre de 2025 | $-0.03 | $-0.04 | 32.4% | |
| 30 de junio de 2025 | $-0.04 | $-0.04 | 2.0% | |
| 31 de marzo de 2025 | $-0.05 | $-0.07 | 24.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $460M | $399M | $267M | $215M | $144M | $49M | $13M | |
| Cost of Revenue | $191M | $147M | $96M | $74M | $52M | $17M | $4M | |
| R&D Expense | $221M | $235M | $266M | $286M | $573M | $223M | $142M | |
| SG&A Expense | $278M | $299M | $282M | $259M | $219M | $111M | $70M | |
| Operating Income | $-229M | $-282M | $-367M | $-404M | $-700M | $-302M | $-203M | |
| Interest Expense | · | $2M | $0 | $0 | $0 | $181.0K | $293.0K | |
| Interest Income | $33M | $37M | $40M | $15M | $2M | $5M | $8M | |
| Other Non-op | $4M | $5M | $7M | $3M | $-10M | $7M | $938.0K | |
| Pretax Income | $-178M | $-257M | $-335M | $-443M | $-704M | $-269M | $-194M | |
| Income Tax | $-3M | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-176M | $-257M | $-335M | $-443M | $-704M | $-269M | $-195M | |
| EPS (Basic) | $-0.16 | $-0.26 | $-0.35 | $-0.46 | $-0.76 | $-0.35 | · | |
| EPS (Diluted) | $-0.16 | $-0.26 | $-0.35 | $-0.46 | $-0.76 | $-0.35 | · | |
| Shares (Basic) | 1,095,311,090 | 989,477,730 | 966,394,130 | 958,067,140 | 929,921,120 | 776,677,430 | · | |
| Shares (Diluted) | 1,095,311,090 | 989,477,730 | 966,394,130 | 958,067,140 | 929,921,120 | 776,677,430 | · | |
| EBITDA | $-214M | $-270M | $-358M | · | $-694M | $-297M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $680M | $450M | $790M | $1.01B | $964M | $442M | $76M | |
| Short-term Investments | $10M | $330M | $16M | $0 | $445M | $745M | $200M | |
| Receivables | $106M | $85M | $59M | $40M | $47M | $5M | $4M | |
| Inventory | $75M | $40M | $45M | $32M | $19M | $13M | $6M | |
| Prepaid Expense | $37M | $42M | $23M | $36M | $18M | $11M | $7M | |
| Current Assets | $1.02B | $1.05B | $940M | $1.12B | $1.50B | $1.22B | $292M | |
| PP&E (Net) | $47M | $48M | $54M | $58M | $43M | $29M | $21M | |
| PP&E (Gross) | $90M | $85M | $84M | $80M | $60M | $39M | $27M | |
| Accum. Depreciation | $42M | $37M | $30M | $22M | $16M | $10M | $5M | |
| Intangibles | $76M | $56M | $13M | $2M | $2M | $2M | $1M | |
| Other Non-current Assets | $3M | $6M | · | · | · | · | · | |
| Total Assets | $1.17B | $1.19B | $1.04B | $1.22B | $1.61B | $1.30B | $355M | |
| Accounts Payable | $142M | $101M | $113M | $66M | $126M | $63M | $23M | |
| Short-term Debt | $205M | $132M | $0 | · | · | · | $6M | |
| Current Liabilities | $416M | $299M | $203M | $140M | $193M | $98M | $47M | |
| Capital Leases | $13M | $14M | $8M | $13M | $10M | $13M | $11M | |
| Other Non-current Liabilities | $0 | $325.0K | $325.0K | $0 | · | · | · | |
| Total Liabilities | $457M | $345M | $240M | $175M | $230M | $128M | $60M | |
| Total Debt | $205M | $132M | · | · | · | · | · | |
| Common Stock | $7.0K | $7.0K | $6.0K | $6.0K | $6.0K | $5.0K | $4.0K | |
| Retained Earnings | $-2.63B | $-2.45B | $-2.20B | $-1.86B | $-1.42B | $-714M | $-445M | |
| Treasury Stock | $29M | $21M | $21M | $12M | $4M | $0 | · | |
| AOCI | $30M | $51M | $38M | $26M | $-24M | $-15M | $5M | |
| Stockholders' Equity | $716M | $841M | $796M | $1.05B | $1.38B | $1.17B | $295M | |
| Liabilities + Equity | $1.17B | $1.19B | $1.04B | $1.22B | $1.61B | $1.30B | $355M | |
| Shares Outstanding | 1,106,389,340 | 1,082,614,740 | 977,151,270 | 962,455,850 | 955,363,980 | 878,110,260 | 682,372,470 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $12M | $9M | $8M | $6M | $5M | $4M | |
| Stock-based Comp | $66M | $71M | $80M | $61M | $41M | $25M | $20M | |
| Amort. of Intangibles | $6M | $3M | $700.0K | $500.0K | $500.0K | $300.0K | $305.0K | |
| Other Non-cash | $-56M | $-40M | $48M | · | $108M | $23M | · | |
| Operating Cash Flow | $-151M | $-215M | $-198M | $-368M | $-549M | $-216M | $-191M | |
| CapEx | $8M | $6M | $7M | $25M | $18M | $10M | $6M | |
| Investing Cash Flow | $308M | $-375M | $-11M | $420M | $250M | $-555M | $-15M | |
| Stock Issued | $0 | $217M | $0 | $0 | · | · | · | |
| Net Stock Activity | $0 | $217M | · | · | · | · | · | |
| Financing Cash Flow | $72M | $350M | $-6M | $-2M | $820M | $1.13B | $219M | |
| Net Change in Cash | $230M | $-240M | $-218M | $44M | $522M | $366M | $13M | |
| Free Cash Flow | $-159M | $-221M | $-205M | · | $-568M | $-226M | · | |
| Levered FCF | · | $-223M | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -49.9% | -70.7% | -137.4% | · | -485.1% | -616.5% | · | |
| Net Margin | -38.1% | -64.4% | -125.5% | · | -488.2% | -549.3% | · | |
| Pretax Margin | -38.8% | -64.4% | -125.5% | · | -487.4% | -549.3% | · | |
| EBITDA Margin | -46.6% | -67.7% | -134.1% | · | -480.6% | -607.0% | · | |
| ROA | -14.9% | -23.1% | -29.7% | · | -48.5% | -32.5% | · | |
| ROE | -23.3% | -34.1% | -39.9% | · | -47.5% | -23.3% | · | |
| ROIC | -24.5% | -29.0% | -46.1% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 3.5 | 4.6 | · | 7.8 | 12.4 | · | |
| Quick Ratio | 1.9 | 2.9 | 4.3 | · | 7.6 | 12.2 | · | |
| Debt / Equity | 0.3 | 0.2 | · | · | · | · | · | |
| Interest Coverage | · | -125.2 | · | · | · | -1667.4 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.2 | · | 0.1 | 0.1 | · | |
| Inventory Turnover | 3.3 | 3.5 | 2.5 | · | 3.3 | 1.7 | · | |
| Receivables Turnover | 4.8 | 5.5 | 5.4 | · | 5.5 | 10.9 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.65 | $0.78 | $0.82 | · | $14.44 | $13.32 | · | |
| Revenue / Share | $0.42 | $0.40 | $0.28 | · | · | · | · | |
| Cash Flow / Share | $-0.14 | $-0.22 | $-0.21 | · | · | · | · | |
| Cash / Share | $0.61 | $0.42 | $0.81 | · | $10.09 | $5.03 | · | |
| EPS (TTM) | $-0.16 | $-0.26 | $-0.35 | $-0.46 | $-0.76 | $-0.35 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.3% | 49.6% | 24.0% | 49.0% | 194.8% | · | · | |
| Revenue CAGR 3Y | 28.9% | 40.4% | 76.0% | · | · | · | · | |
| Revenue CAGR 5Y | 56.5% | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $460M | $399M | $267M | $215M | $144M | $49M | · | |
| Net Income TTM | $-176M | $-257M | $-335M | $-443M | $-704M | $-269M | · | |
| Market Cap | $19.52B | $28.23B | $26.57B | · | $6.00B | $11.88B | · | |
| Enterprise Value | $19.03B | $27.58B | · | · | · | · | · | |
| P/E | -110.2 | -100.7 | -78.1 | -66.7 | -82.7 | -386.7 | · | |
| P/S | 42.4 | 70.7 | 99.6 | · | 41.6 | 242.7 | · | |
| P/B | 27.3 | 33.6 | 33.4 | · | 4.4 | 10.2 | · | |
| P / Tangible Book | 30.5 | 36.0 | 33.9 | 28.2 | 4.4 | 10.2 | · | |
| P / Cash Flow | -129.4 | -131.4 | -134.1 | · | -10.9 | -55.0 | · | |
| P / FCF | -122.8 | -128.0 | -129.4 | · | -10.6 | -52.5 | · | |
| EV / EBITDA | -88.8 | -102.0 | · | · | · | · | · | |
| EV / FCF | -119.8 | -125.1 | · | · | · | · | · | |
| EV / Revenue | 41.4 | 69.1 | · | · | · | · | · | |
| Earnings Yield | -0.91% | -0.99% | -1.3% | -1.5% | -1.2% | -0.26% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106M | $100M | $128M | $116M | $110M | $106M | $109M | $102M | $101M | $87M | $66M | $69M | $69M | $63M | $63M | $58M | |
| Cost of Revenue | $48M | $38M | $62M | $47M | $43M | $38M | $42M | $37M | $35M | $34M | $25M | $25M | $24M | $21M | $21M | $20M | |
| R&D Expense | $62M | $66M | $62M | $48M | $51M | $61M | $52M | $66M | $62M | $55M | $82M | $59M | $77M | $48M | $67M | $100M | |
| SG&A Expense | $73M | $65M | $73M | $70M | $71M | $63M | $83M | $67M | $80M | $69M | $83M | $69M | $68M | $63M | $72M | $67M | |
| Operating Income | $-76M | $-69M | $-69M | $-49M | $-55M | $-56M | $-68M | $-68M | $-76M | $-70M | $-124M | $-84M | $-90M | $-70M | $-97M | $-129M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $113.0K | · | · | · | $0 | · | · | |
| Interest Income | $6M | $6M | $7M | $8M | $9M | $9M | $9M | $9M | $9M | $10M | $10M | $9M | $10M | $10M | $9M | $4M | |
| Other Non-op | $5M | $162.0K | $495.0K | $-508.0K | $4M | $-197.0K | $1M | $3M | $-9M | $9M | $7M | $394.0K | $-1M | $1M | $10M | $4M | |
| Pretax Income | $-52M | $-50M | $-53M | $-36M | $-41M | $-48M | $-82M | $-42M | $-80M | $-53M | $-95M | $-69M | $-121M | $-49M | $-62M | $-161M | |
| Income Tax | $-1M | $1M | $-3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-51M | $-51M | $-50M | $-36M | $-41M | $-48M | $-82M | $-42M | $-80M | $-53M | $-95M | $-69M | $-121M | $-49M | $-62M | $-161M | |
| EPS (Basic) | $-0.05 | $-0.05 | $-0.05 | $-0.03 | $-0.04 | $-0.04 | $-0.09 | $-0.04 | $-0.08 | $-0.05 | $-0.10 | $-0.07 | $-0.13 | $-0.05 | $-0.06 | $-0.17 | |
| EPS (Diluted) | $-0.05 | $-0.05 | $-0.05 | $-0.03 | $-0.04 | $-0.04 | $-0.09 | $-0.04 | $-0.08 | $-0.05 | $-0.10 | $-0.07 | $-0.13 | $-0.05 | $-0.06 | $-0.17 | |
| Shares (Basic) | 1,116,973,380 | 1,107,390,590 | · | 1,102,072,680 | 1,091,933,150 | 1,080,825,300 | · | 981,687,390 | 975,937,790 | 973,145,760 | · | 968,767,730 | 964,817,310 | 961,444,780 | · | 959,085,960 | |
| Shares (Diluted) | 1,116,973,380 | 1,107,390,590 | · | 1,102,072,680 | 1,091,933,150 | 1,080,825,300 | · | 981,687,390 | 975,937,790 | 973,145,760 | · | 968,767,730 | 964,817,310 | 961,444,780 | · | 959,085,960 | |
| EBITDA | $-76M | $-65M | · | $-49M | $-55M | $-53M | · | $-68M | $-76M | $-67M | · | $-84M | $-90M | $-67M | · | $-129M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $608M | $651M | $680M | $717M | $732M | $757M | $450M | $616M | $630M | $651M | · | $789M | $859M | $880M | · | $1.12B | |
| Short-term Investments | $10M | $10M | $10M | $0 | $0 | $0 | $330M | $0 | $0 | $0 | · | $32M | $16M | $51M | · | $0 | |
| Receivables | $70M | $54M | $106M | $85M | $88M | $77M | $85M | $50M | $70M | $60M | · | $42M | $47M | $43M | · | $28M | |
| Inventory | $91M | $86M | $75M | $67M | $62M | $53M | $40M | $40M | $42M | $38M | · | $44M | $36M | $38M | · | $29M | |
| Prepaid Expense | $33M | $35M | $37M | $44M | $41M | $44M | $42M | $36M | $20M | $24M | · | $30M | $38M | $43M | · | $22M | |
| Current Assets | $914M | $945M | $1.02B | $1.03B | $1.03B | $1.04B | $1.05B | $861M | $870M | $889M | · | $960M | $1.02B | $1.07B | · | $1.21B | |
| PP&E (Net) | $46M | $47M | $47M | $49M | $50M | $50M | $48M | $51M | $51M | $52M | · | $55M | $56M | $58M | · | $51M | |
| PP&E (Gross) | $94M | $92M | $90M | $89M | $89M | $89M | $85M | $87M | $85M | $85M | · | $83M | $82M | $83M | · | $71M | |
| Accum. Depreciation | $47M | $45M | $42M | $41M | $39M | $39M | $37M | $36M | $34M | $32M | · | $28M | $26M | $24M | · | $20M | |
| Intangibles | $86M | $76M | $76M | $55M | $57M | $56M | $56M | $52M | $44M | $12M | · | $2M | $2M | $1M | · | $2M | |
| Other Non-current Assets | $4M | $3M | $3M | $2M | $3M | $3M | $6M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $1.07B | $1.10B | $1.17B | $1.16B | $1.16B | $1.17B | $1.19B | $985M | $987M | $988M | · | $1.04B | $1.11B | $1.17B | · | $1.30B | |
| Accounts Payable | $137M | $126M | $142M | $100M | $107M | $103M | $101M | $121M | $127M | $88M | · | $55M | $67M | $66M | · | $90M | |
| Short-term Debt | $238M | $214M | $205M | $203M | $175M | $173M | $132M | $113M | $70M | $48M | · | · | · | · | · | · | |
| Current Liabilities | $429M | $393M | $416M | $360M | $332M | $320M | $299M | $286M | $252M | $192M | · | $125M | $133M | $125M | · | $156M | |
| Capital Leases | $11M | $12M | $13M | $11M | $11M | $12M | $14M | $6M | $6M | $8M | · | $10M | $12M | $13M | · | $14M | |
| Other Non-current Liabilities | $225.0K | $40.0K | $0 | $325.0K | $325.0K | $325.0K | $325.0K | $325.0K | $325.0K | $325.0K | · | $325.0K | $325.0K | $325.0K | · | · | |
| Total Liabilities | $468M | $434M | $457M | $399M | $372M | $363M | $345M | $318M | $283M | $226M | · | $163M | $174M | $169M | · | $193M | |
| Total Debt | $238M | $214M | · | $203M | $175M | $173M | · | $113M | $70M | $48M | · | · | · | · | · | · | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $-2.73B | $-2.68B | $-2.63B | $-2.58B | $-2.54B | $-2.50B | $-2.45B | $-2.37B | $-2.33B | $-2.25B | · | $-2.10B | $-2.03B | $-1.91B | · | $-1.80B | |
| Treasury Stock | $34M | $31M | $29M | $29M | $21M | $21M | $21M | $21M | $21M | $21M | · | $21M | $21M | $17M | · | $11M | |
| AOCI | $214.0K | $15M | $30M | $40M | $46M | $49M | $51M | $28M | $43M | $39M | · | $48M | $52M | $17M | · | $40M | |
| Stockholders' Equity | $607M | $662M | $716M | $760M | $792M | $811M | $841M | $668M | $704M | $762M | $796M | $881M | $932M | $1.00B | $1.05B | $1.11B | |
| Liabilities + Equity | $1.07B | $1.10B | $1.17B | $1.16B | $1.16B | $1.17B | $1.19B | $985M | $987M | $988M | · | $1.04B | $1.11B | $1.17B | · | $1.30B | |
| Shares Outstanding | 1,122,445,390 | 1,110,232,620 | 1,106,389,340 | 1,105,865,950 | 1,099,112,890 | 1,084,164,200 | 1,077,702,540 | 984,356,170 | 981,398,140 | 973,285,510 | 977,151,270 | 969,037,150 | 968,566,280 | 963,688,740 | 962,455,850 | 959,724,940 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Stock-based Comp | $12M | $14M | $16M | $17M | $17M | $16M | $17M | $17M | $19M | $18M | $20M | $22M | $21M | $17M | $16M | $19M | |
| Amort. of Intangibles | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $700.0K | $800.0K | $700.0K | $200.0K | $200.0K | · | · | · | · | |
| Other Non-cash | · | $22M | · | · | · | $-33M | · | · | · | $-58M | · | · | · | $-39M | · | · | |
| Operating Cash Flow | $-63M | $-12M | $-26M | $-32M | $-31M | $-62M | $-56M | $-27M | $-42M | $-90M | $-15M | $-55M | $-59M | $-69M | $-109M | $-126M | |
| CapEx | $1M | $1M | $677.0K | $3M | $3M | $2M | $3M | $1M | $741.0K | $974.0K | $222.0K | $2M | $2M | $4M | $4M | $7M | |
| Investing Cash Flow | $-1M | $-22M | $-11M | $-4M | $-3M | $326M | $-348M | $-30M | $-846.0K | $3M | $14M | $-14M | $43M | $-54M | $-4M | $568M | |
| Financing Cash Flow | $19M | $6M | $-430.0K | $21M | $9M | $43M | $238M | $42M | $22M | $48M | $393.0K | $-1M | $-1M | $-4M | $-199.0K | $709.0K | |
| Net Change in Cash | $-44M | $-28M | $-38M | $-15M | $-25M | $308M | $-166M | $-14M | $-21M | $-39M | $666.0K | $-70M | $-20M | $-128M | $-111M | $439M | |
| Free Cash Flow | · | $-13M | · | · | · | $-63M | · | · | · | $-91M | · | · | · | $-73M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-91M | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -72.0% | -69.7% | · | -42.0% | -49.9% | -52.9% | · | -66.3% | -75.7% | -80.7% | · | -120.7% | -130.0% | -110.7% | · | -223.5% | |
| Net Margin | -47.8% | -51.2% | · | -31.0% | -37.0% | -45.5% | · | -40.8% | -79.9% | -61.4% | · | -99.9% | -175.6% | -78.3% | · | -280.1% | |
| Pretax Margin | -48.8% | -49.8% | · | -31.0% | -37.0% | -45.5% | · | -40.8% | -79.9% | -61.4% | · | -99.9% | -175.6% | -78.3% | · | -280.1% | |
| EBITDA Margin | -72.0% | -65.7% | · | -42.0% | -49.9% | -49.6% | · | -66.3% | -75.7% | -77.2% | · | -120.7% | -130.0% | -106.5% | · | -223.5% | |
| ROA | -4.5% | -4.5% | · | -3.4% | -3.8% | -4.5% | · | -4.1% | -7.7% | -5.0% | · | -5.9% | -9.6% | -3.7% | · | -10.7% | |
| ROE | -7.3% | -6.9% | · | -5.0% | -5.5% | -6.2% | · | -5.4% | -9.8% | -6.1% | · | -7.0% | -11.3% | -4.3% | · | -12.0% | |
| ROIC | -8.9% | -8.2% | · | -5.1% | -5.7% | -5.7% | · | -8.7% | -9.8% | -8.7% | · | -9.5% | -9.6% | -6.9% | · | -11.6% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.4 | · | 2.9 | 3.1 | 3.3 | · | 3.0 | 3.5 | 4.6 | · | 7.7 | 7.6 | 8.6 | · | 7.8 | |
| Quick Ratio | 1.6 | 1.8 | · | 2.2 | 2.5 | 2.6 | · | 2.3 | 2.8 | 3.7 | · | 6.9 | 6.9 | 7.8 | · | 7.4 | |
| Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -622.2 | · | · | · | · | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.9 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.7 | 0.8 | 0.7 | · | 1.0 | |
| Receivables Turnover | 1.3 | 1.5 | · | 1.7 | 1.4 | 1.6 | · | 2.2 | 1.7 | 1.7 | · | 2.0 | 1.9 | 1.6 | · | 2.4 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.54 | $0.60 | · | $0.69 | $0.72 | $0.75 | · | $0.68 | $0.72 | $0.78 | · | $0.91 | $0.96 | $1.04 | · | $1.15 | |
| Revenue / Share | $0.10 | $0.09 | · | $0.11 | $0.10 | $0.10 | · | $0.10 | $0.10 | $0.09 | · | $0.07 | $0.07 | $0.07 | · | $0.06 | |
| Cash Flow / Share | · | $-0.01 | · | · | · | $-0.06 | · | · | · | $-0.09 | · | · | · | $-0.07 | · | · | |
| Cash / Share | $0.54 | $0.59 | · | $0.65 | $0.67 | $0.70 | · | $0.63 | $0.64 | $0.67 | · | $0.81 | $0.89 | $0.91 | · | $1.17 | |
| EPS (TTM) | $-0.18 | $-0.17 | · | $-0.20 | $-0.21 | $-0.25 | · | $-0.27 | $-0.30 | $-0.35 | · | $-0.31 | $-0.41 | $-0.42 | · | $-0.63 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $450M | $453M | · | $442M | $428M | $418M | · | $356M | $323M | $291M | · | $263M | $252M | $231M | · | $197M | |
| Net Income TTM | $-188M | $-178M | · | $-207M | $-213M | $-252M | · | $-271M | $-298M | $-339M | · | $-301M | $-393M | $-410M | · | $-593M | |
| Market Cap | $21.33B | $20.88B | · | $37.48B | $38.44B | $39.18B | · | $23.76B | $17.01B | $15.59B | · | $23.56B | $26.86B | $32.05B | · | $32.82B | |
| Enterprise Value | $20.95B | $20.44B | · | $36.96B | $37.88B | $38.60B | · | $23.26B | $16.45B | $14.99B | · | · | · | · | · | · | |
| P/E | -105.6 | -110.6 | · | -169.4 | -166.5 | -144.6 | · | -89.4 | -57.8 | -45.8 | · | -78.4 | -67.6 | -79.2 | · | -54.3 | |
| P/S | 47.4 | 46.1 | · | 84.9 | 89.8 | 93.7 | · | 66.8 | 52.7 | 53.6 | · | 89.4 | 106.7 | 138.7 | · | 166.9 | |
| P/B | 35.1 | 31.5 | · | 49.3 | 48.5 | 48.3 | · | 35.6 | 24.2 | 20.5 | · | 26.7 | 28.8 | 32.0 | · | 29.7 | |
| P / Tangible Book | 40.9 | 35.6 | · | 53.2 | 52.3 | 51.9 | · | 38.6 | 25.8 | 20.8 | · | 26.8 | 28.9 | 32.1 | · | 29.7 | |
| P / Cash Flow | · | -1753.1 | · | · | · | -635.0 | · | · | · | -173.0 | · | · | · | -462.6 | · | · | |
| EV / Revenue | 46.6 | 45.1 | · | 83.7 | 88.5 | 92.3 | · | 65.4 | 51.0 | 51.5 | · | · | · | · | · | · | |
| Earnings Yield | -0.95% | -0.90% | · | -0.59% | -0.60% | -0.69% | · | -1.1% | -1.7% | -2.2% | · | -1.3% | -1.5% | -1.3% | · | -1.8% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $460M | $399M | $267M | $215M | $144M |
| Margen Operativo % | -49.9% | -70.7% | -137.4% | · | -485.1% |
| Beneficio neto | $-176M | $-257M | $-335M | $-443M | $-704M |
| EPS Diluido | $-0.16 | $-0.26 | $-0.35 | $-0.46 | $-0.76 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.3 | 0.2 | · | · | · |
| Ratio corriente | 2.4 | 3.5 | 4.6 | · | 7.8 |
| Ratio Rápido | 1.9 | 2.9 | 4.3 | · | 7.6 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-159M | $-221M | $-205M | · | $-568M |
Propietarios institucionales (13F) 97 declarantes · $813.8M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
97
Valor en tenencia
$813.8M
Nuevas posiciones
16
Posiciones cerradas
21
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 16 (-4 vs trimestre anterior) | 21 (-20 vs trimestre anterior) | 29 (+5 vs trimestre anterior) | 26 (-17 vs trimestre anterior) | +15.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $124 906 608 | 6 574 032 | 15,35% | Acciones |
| TCG Crossover Management, LLC | $116 614 913 | 6 137 627 | 14,33% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $109 127 127 | 5 743 533 | 13,41% | Acciones |
| ADAR1 Capital Management, LLC | $64 011 646 | 3 369 034 | 7,87% | Acciones |
| FMR LLC | $53 489 066 | 2 815 214 | 6,57% | Acciones |
| GOLDMAN SACHS GROUP INC | $43 994 120 | 2 315 480 | 5,41% | Acciones |
| Woodline Partners LP | $41 938 567 | 2 207 293 | 5,15% | Acciones |
| Frazier Life Sciences Management, L.P. | $36 144 080 | 1 902 320 | 4,44% | Acciones |
| BAMCO INC /NY/ | $30 850 186 | 1 623 694 | 3,79% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $24 688 486 | 1 299 394 | 3,03% | Acciones |
| CITADEL ADVISORS LLC | $24 409 414 | 1 284 706 | 3,00% | Acciones |
| Rock Springs Capital Management LP | $15 479 433 | 814 707 | 1,90% | Acciones |
| BlackRock, Inc. | $12 624 778 | 664 462 | 1,55% | Acciones |
| JANE STREET GROUP, LLC | $9 054 279 | 476 541 | 1,11% | Acciones |
| B Group, Inc. | $8 562 274 | 450 646 | 1,05% | Acciones |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $7 238 204 | 393 167 | 0,89% | Acciones |
| NAN FUNG TRINITY (HK) LTD | $6 582 854 | 346 466 | 0,81% | Acciones |
| Aberdeen Group plc | $5 914 586 | 311 294 | 0,73% | Acciones |
| CITIGROUP INC | $5 714 725 | 300 775 | 0,70% | Acciones |
| Spruce Street Capital LP | $5 303 090 | 279 110 | 0,65% | Acciones |
| AMERIPRISE FINANCIAL INC | $4 810 249 | 253 171 | 0,59% | Acciones |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4 692 658 | 246 982 | 0,58% | Acciones |
| Hudson Bay Capital Management LP | $4 085 000 | 215 000 | 0,50% | Acciones |
| JANE STREET GROUP, LLC | $3 864 600 | 203 400 | 0,47% | Opción de venta |
| Nantahala Capital Management, LLC | $3 800 000 | 200 000 | 0,47% | Acciones |
| NEXTBio Capital Management LP | $3 483 878 | 183 362 | 0,43% | Acciones |
| SUPERSTRING CAPITAL MANAGEMENT LP | $2 960 447 | 155 813 | 0,36% | Acciones |
| Seven Fleet Capital Management LP | $2 924 756 | 136 016 | 0,36% | Acciones |
| MARSHALL WACE, LLP | $2 797 123 | 147 217 | 0,34% | Acciones |
| D. E. Shaw & Co., Inc. | $2 682 002 | 141 158 | 0,33% | Acciones |
| Privium Fund Management B.V. | $2 321 591 | 122 189 | 0,29% | Acciones |
| STATE STREET CORP | $2 296 074 | 120 846 | 0,28% | Acciones |
| AXA Investment Managers S.A. | $2 230 436 | 65 814 | 0,27% | Acciones |
| ALPS ADVISORS INC | $2 098 189 | 110 431 | 0,26% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 086 200 | 109 800 | 0,26% | Opción de venta |
| DIMENSIONAL FUND ADVISORS LP | $1 934 621 | 101 997 | 0,24% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 454 735 | 76 565 | 0,18% | Acciones |
| Legal & General Group Plc | $1 358 116 | 71 461 | 0,17% | Acciones |
| UBS Group AG | $1 319 626 | 69 454 | 0,16% | Acciones |
| Orion Portfolio Solutions, LLC | $1 310 400 | 36 259 | 0,16% | Acciones |
| Virtus Investment Advisers, LLC | $1 294 356 | 68 124 | 0,16% | Acciones |
| Headlands Technologies LLC | $1 292 190 | 68 010 | 0,16% | Acciones |
| MORGAN STANLEY | $1 242 619 | 65 401 | 0,15% | Acciones |
| DCF Advisers, LLC | $1 206 500 | 63 500 | 0,15% | Acciones |
| CITADEL ADVISORS LLC | $953 800 | 50 200 | 0,12% | Opción de venta |
| Quadrature Capital Ltd | $741 532 | 39 028 | 0,09% | Acciones |
| WOLVERINE TRADING, LLC | $714 581 | 21 700 | 0,09% | Opción de venta |
| WealthPlan Investment Management, LLC | $698 459 | 36 761 | 0,09% | Acciones |
| NORTHERN TRUST CORP | $455 601 | 23 979 | 0,06% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $453 701 | 23 879 | 0,06% | Acciones |
Informantes de la empresa 20 insiders · 11 directivos · 10 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Ying Du | Chairperson & CEO | 2 de julio de 2026 A | 1 221 401 | 0 | 15 | $-8 578 643 |
| Yajing Chen | Chief Financial Officer | 19 de agosto de 2026 S | 35 635 | 0 | 8 | $-239 260 |
| William Ki Chul Cho | Chief Financial Officer | 3 de abril de 2023 M | 53 747 | 0 | 0 | $0 |
| Joshua L Smiley | President and Chief Operating Officer | 6 de abril de 2026 S | 117 602 | 0 | 3 | $-294 354 |
| Rafael Amado | President, Head of Global Oncology Research and Development | 6 de abril de 2026 S | 57 022 | 0 | 5 | $-674 984 |
| Harald Reinhart | President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases | 25 de junio de 2024 M | 62 619 | 0 | 0 | $0 |
| Yi Liang | CCO & President, Greater China | 25 de junio de 2022 A | 104 847 | 0 | 0 | $0 |
| Tao Fu | President & COO | 28 de octubre de 2021 S | 77 500 | 0 | 0 | $0 |
| Frazor Titus Edmondson III | Chief Legal Officer | 25 de junio de 2026 M | 30 346 | 0 | 8 | $-1 005 489 |
| Yizhe Wang | Operating Partner | 11 de mayo de 2026 A | · | 0 | 0 | $0 |
| Alan B. Sandler | Head of Global Dev., Oncology | 25 de junio de 2022 A | 28 985 | 0 | 0 | $0 |
| Richard Gaynor | Consejero | 1 de julio de 2026 P | 80 737 | 2 | 0 | $65 804 |
| Nisa Leung | Consejero | 17 de junio de 2026 A | 96 297 | 0 | 0 | $0 |
| Michel Vounatsos | Consejero | 17 de junio de 2026 A | 72 787 | 0 | 0 | $0 |
| Scott W Morrison | Consejero | 17 de junio de 2026 A | 56 904 | 0 | 0 | $0 |
| John D. Diekman | Consejero | 17 de junio de 2026 A | 122 140 | 0 | 0 | $0 |
| MOULDER LEON O JR | Consejero | 17 de junio de 2026 A | 94 973 | 0 | 0 | $0 |
| WIRTH PETER | Consejero | 17 de junio de 2026 A | 416 121 | 0 | 0 | $0 |
| Kai-Xian Chen | Consejero | 31 de diciembre de 2024 D | 39 525 | 0 | 0 | $0 |
| William Lis | · | 12 de agosto de 2026 S | 41 931 | 0 | 2 | $-340 004 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 8 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,47% | 79 505 NS | 31 de julio de 2026 | N-PORT |
| PGJ · Invesco Exchange-Traded Fund Trust | 0,86% | 28 106 SH | 2 de octubre de 2026 | Diario |
| IBB · iShares Trust | 0,16% | 684 677 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 3 144 SH | 2 de octubre de 2026 | Diario |
| DFEM · Dimensional ETF Trust | 0,01% | 26 020 NS | 31 de julio de 2026 | N-PORT |
| DFSE · Dimensional ETF Trust | 0,01% | 1 660 NS | 31 de julio de 2026 | N-PORT |
| DFAE · Dimensional ETF Trust | 0,00% | 10 010 NS | 31 de julio de 2026 | N-PORT |
| DFAX · Dimensional ETF Trust | 0,00% | 2 911 NS | 31 de julio de 2026 | N-PORT |
ZLAB Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 15 analistas
COMPRA
Objetivo mediano
$31.84
+30,9%
2 13,3%
Compra fuerte
10 66,7%
Compra
3 20,0%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
12 analistas · 2026-09-29Objetivo medio $33.14 +36,2%
Ahora
Precio Actual $24.33
Mín$24.25
Media$33.14
Máx$50.00
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026